stoxline Quote Chart Rank Option Currency Glossary
Fortrea Holdings Inc. (FTRE)
37.71  1.21 (3.32%)    02-27 15:38
Open: 36.5
High: 37.93
Volume: 496,704
Pre. Close: 36.5
Low: 36.4093
Market Cap: 3,349(M)
Technical analysis
2024-02-27 3:15:16 PM
Short term     
Mid term     
Targets 6-month :  44.93 1-year :  52.48
Resists First :  38.47 Second :  44.93
Pivot price 34.35
Supports First :  33.33 Second :  30.15
MAs MA(5) :  36.8 MA(20) :  33.51
MA(100) :  31.42 MA(250) :  0
MACD MACD :  1.4 Signal :  0.9
%K %D K(14,3) :  80.6 D(3) :  81.2
RSI RSI(14): 73.7
52-week High :  38.47 Low :  24.92
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ FTRE ] has closed below upper band by 13.3%. Bollinger Bands are 83.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 5 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 37.18 - 37.43 37.43 - 37.63
Low: 35.97 - 36.21 36.21 - 36.42
Close: 36.14 - 36.54 36.54 - 36.87
Company Description

Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. It operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is based in Durham, North Carolina.

Headline News

Sat, 24 Feb 2024
Fortrea Holdings Inc. (NASDAQ:FTRE) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Fri, 23 Feb 2024
With A 3.9% Return On Equity, Is Fortrea Holdings Inc. (NASDAQ:FTRE) A Quality Stock? - Yahoo Finance UK

Tue, 20 Feb 2024
Fortrea to Present at the Barclays 26th Annual Global Healthcare Conference - Yahoo Finance

Tue, 13 Feb 2024
Fortrea Stock: High Risk And Low Upside Potential (NASDAQ:FTRE) - Seeking Alpha

Tue, 30 Jan 2024
Fortrea Holdings Inc. (NASDAQ:FTRE) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Fri, 05 Jan 2024
Vltava Fund Sold Fortrea Holdings (FTRE) for an Attractive Price - Insider Monkey

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Shares Out 89 (M)
Shares Float 75 (M)
Held by Insiders 0 (%)
Held by Institutions 121.6 (%)
Shares Short 4,970 (K)
Shares Short P.Month 4,800 (K)
Stock Financials
EPS -0.77
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 19.07
Profit Margin 2.1 %
Operating Margin 3.2 %
Return on Assets (ttm) 0 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 1.8 %
Gross Profit (p.s.) 0
Sales Per Share 34.9
EBITDA (p.s.) 2.94
Qtrly Earnings Growth 0 %
Operating Cash Flow 183 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio -48.82
PEG Ratio 0
Price to Book value 1.96
Price to Sales 1.07
Price to Cash Flow 18.2
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android